We hypothesized that an interrogation of the phosphoproteome might inform about mechanistic traits not capturable in gene-centric layers19,20, aiming to understand the basic kinome landscapes underlying the response to the cytotoxic agent paclitaxel in HER2-negative breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.